Surfactin C inhibits the lipopolysaccharide-induced transcription of interleukin-1β and inducible nitric oxide synthase and nitric oxide production in murine RAW 264.7 cells

Biotechnology Letters

Volumn 27, Issue 20, 2005, Pages 1605-1608

  Hwang, Mi Hyun ^a   Lim, Jong Hwan ^b   Yun, Hyo In ^b   Rhee, Man Hee ^a   Cho, Jae Youl ^c   Hsu, Walter H ^d   Park, Seung Chun ^a  

^a Kyungpook National University   (South Korea)

^b Chungnam National University   (South Korea)

^c Kangwon National University   (South Korea)

^d IOWA STATE UNIVERSITY   (United States)

Author keywords

Cyclooxygenase; Cytokine; Interleukin 1 ; Nitric oxide; Surfactin

Indexed keywords

CELLS; ENZYMES; POLYSACCHARIDES;

CYCLOOXYGENASE; CYTOKINE; INTERLEUKIN-1Β; NITRIC OXIDE; SURFACTIN;

ENZYME INHIBITION;

BACTERIAL PROTEIN; CYCLOPEPTIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; NOS2 PROTEIN, MOUSE; SURFACTIN C;

ANIMAL; ARTICLE; BACILLUS SUBTILIS; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; MOUSE;

ANIMALS; BACILLUS SUBTILIS; BACTERIAL PROTEINS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MICE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDES, CYCLIC; TRANSCRIPTION, GENETIC;

BACILLUS SUBTILIS; MURINAE;

EID: 27144524870     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-005-2515-1     Document Type: Article

References (12)

1. K Arima A Kakinuma G Tamura 1968 Surfactin, a crystalline peptide lipid surfactant produced by Bacillus subtilis: isolation, characterization and inhibition of fibrin clot formation Biochem. Biophys. Res. Commun. 31 88 494
2. AW Bernheimer LS Avigad 1970 Nature and properties of a cytolytic agent produced by Bacillus subtilis J. Gen. Microbiol. 61 361 369
3. K Hosono H Suzuki 1983 Acylpeptides, the inhibitors of cyclic adenosine 3prime;,5prime;-monophosphate phosphodiesterase III. Inhibition of cyclic AMP phosphodiesterase J. Antibiot. 36 679 683
4. R Ishii M Horie K Saito M Arisawa S Kitanaka 2003 Inhibition of lipopolysaccharide-induced pro-inflammatory cytokine expression via suppression of nuclear factor-KB activation by Mallotus japonicus phloroglucinol derivatives Biochim. Biophys. Acta 1620 108 118
5. Y Kameda S Ouhira K Matsui S Kanatomo 1974 Antitumor activity of Bacillus natto.V. Isolation and characterization of surfactin in the culture medium of Bacillus natto KMD 2311 Chem. Pharm. Bull. 22 938 944
6. T Kikuchi K Hasumi 2002 Enhancement of plasminogen activation by surfactin C: augmentation of fibrinolysis in vitro and in vivo Biochim. Biophys. Acta 29 234 245
7. 2 Biochem. Pharmacol. 55 975 985
8. SH Lee SY Lee DJ Son H Lee HS Yoo S Song KW Oh DC Han BM Kwon JT Hong 2005 Inhibitory effect of 2′-hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-κB activation in RAW 264.7 cells Biochem. Pharmacol. 769 791 799
9. S Nakayama S Takahashi 1997 Isolation of new variants of surfactin by a recombinant Bacillus subtilis Appl. Microbiol. Biotechol. 48 80 82
10. C Nathan QW Xie 1994 Nitric oxide synthases: roles, tolls, and controls Cell 78 915 918
11. N Tsukagoshi G Tamura K Arima 1970 A novel protoplast-bursting factor (surfactin) obtained from Bacillus subtilis IAM 1213. II. The interaction of surfactin with bacterial membranes and lipids Biochim. Biophys. Acta 196 211 214
12. D Vollenbroich G Pauli M Ozel J Vater 1997 Antimycoplasma properties and application in cell culture of surfactin, a lipopeptide antibiotic from Bacillus subtilis Appl. Environ. Microbiol. 63 44 49